Cryo-EM structure of the human adenosine A1 receptor (A1R, white) in complex with the orthosteric agonist adenosine (magenta) ...

Chronic pain affects millions of people in the US. Targeting an oft-overlooked brain receptor could one day offer relief.

A painkiller developed by Germany's Algiax Pharma has shown efficacy in the treatment of chronic neuropathic pain, another positive development in the search for alternatives to opioids. The phase ...

In her new book, “Mind Your Body: A Revolutionary Program to Release Chronic Pain and Anxiety,” the author, podcaster and public speaker shares her method for eliminating not just chronic pain ...

Researchers have developed a wireless implant for chronic pain relief. The ultrasound-powered device adapts to individual ...

The success of Vertex's opioid alternative Journavx could aid a group of biotechs that aim to take a similar path with NaV1.8 ...

MIRA is advancing complementary non-opioid therapies for two of the largest pain markets MIAMI, FLORIDA / ACCESS Newswire / ...

Explore how AI-powered wireless implants could replace opioids, using ultrasonic energy to block chronic pain signals without addiction risk.

Shares of Artelo Biosciences, Inc. (ARTL) more than doubled on Monday after the company announced favorable results from its ...

The Global Neuropathic Pain Market is valued approximately at USD 8.14 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.73% over the forecast period 2024-2032.

This groundbreaking device, detailed in Nature Electronics, represents a significant leap forward in pain therapy. While current spinal cord stimulators can be unwieldy and are hard-wired to batteries ...